« Back
Home /
Dihydromyricetin

Dihydromyricetin

Manufacturer	MedChem Express
Category	Oncology Neuroscience Neural Lineage Markers Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Bladder Cancer Bone Cancer Neurodegeneration Markers;Research Area S100 Calcium Binding Protein B Markers
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	10 mg
Item no.	HY-N0112-10mg
Targets	MTOR
CASRN	27200-12-0
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	320.25
Clinical_Information	Phase 2
Manufacturers Research_Area	Cancer; Infection
Solubility	DMSO : ≥ 100 mg/mL
Isoform	mTORC1; mTORC2
Pathway	Anti-infection; Autophagy; Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Manufacturers Product type	Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-N0112-10mg-safety-datasheet.pdf